Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.
Mao J, Wang D, Long J, Yang X, Lin J, Song Y, Xie F, Xun Z, Wang Y, Wang Y, Li Y, Sun H, Xue J, Song Y, Zuo B, Zhang J, Bian J, Zhang T, Yang X, Zhang L, Sang X, Zhao H.
Mao J, et al. Among authors: zuo b.
J Immunother Cancer. 2021 Dec;9(12):e003334. doi: 10.1136/jitc-2021-003334.
J Immunother Cancer. 2021.
PMID: 34873013
Free PMC article.